Wohl BM - Search Results

1

Polyanionic Macromolecular Prodrugs of Ribavirin: Antiviral Agents with a Broad Spectrum of Activity.

Hinton TM, Zuwala K, Deffrasnes C, Todd S, Shi S, Marsh GA, Dearnley M, Wohl BM, Tolstrup M, Zelikin AN. Hinton TM, et al. Among authors: wohl bm. Adv Healthc Mater. 2016 Mar 9;5(5):534-40. doi: 10.1002/adhm.201500841. Epub 2016 Jan 20. Adv Healthc Mater. 2016. PMID: 26789641

2

Macromolecular prodrugs of ribavirin combat side effects and toxicity with no loss of activity of the drug.

Kryger MB, Wohl BM, Smith AA, Zelikin AN. Kryger MB, et al. Among authors: wohl bm. Chem Commun (Camb). 2013 Apr 4;49(26):2643-5. doi: 10.1039/c3cc00315a. Chem Commun (Camb). 2013. PMID: 23431562

3

Macromolecular prodrugs for controlled delivery of ribavirin.

Kryger MB, Smith AA, Wohl BM, Zelikin AN. Kryger MB, et al. Among authors: wohl bm. Macromol Biosci. 2014 Feb;14(2):173-85. doi: 10.1002/mabi.201300244. Epub 2013 Sep 17. Macromol Biosci. 2014. PMID: 24105953

4

Narrow therapeutic window of ribavirin as an inhibitor of nitric oxide synthesis is broadened by macromolecular prodrugs.

Wohl BM, Smith AA, Kryger MB, Zelikin AN. Wohl BM, et al. Biomacromolecules. 2013 Nov 11;14(11):3916-26. doi: 10.1021/bm401048s. Epub 2013 Oct 24. Biomacromolecules. 2013. PMID: 24156371

5

Macromolecular prodrugs of ribavirin: concerted efforts of the carrier and the drug.

Smith AA, Wohl BM, Kryger MB, Hedemann N, Guerrero-Sanchez C, Postma A, Zelikin AN. Smith AA, et al. Among authors: wohl bm. Adv Healthc Mater. 2014 Sep;3(9):1404-7. doi: 10.1002/adhm.201300637. Epub 2014 Jan 10. Adv Healthc Mater. 2014. PMID: 24408515

6

Highly active macromolecular prodrugs inhibit expression of the hepatitis C virus genome in the host cells.

Ruiz-Sanchis P, Wohl BM, Smith AA, Zuwala K, Melchjorsen J, Tolstrup M, Zelikin AN. Ruiz-Sanchis P, et al. Among authors: wohl bm. Adv Healthc Mater. 2015 Jan 7;4(1):65-8. doi: 10.1002/adhm.201400307. Epub 2014 Aug 7. Adv Healthc Mater. 2015. PMID: 25132665

7

Disulfide reshuffling triggers the release of a thiol-free anti-HIV agent to make up fast-acting, potent macromolecular prodrugs.

Kock A, Zuwala K, Smith AA, Ruiz-Sanchis P, Wohl BM, Tolstrup M, Zelikin AN. Kock A, et al. Among authors: wohl bm. Chem Commun (Camb). 2014 Dec 4;50(93):14498-500. doi: 10.1039/c4cc04280h. Chem Commun (Camb). 2014. PMID: 25285337

8

Macromolecular (pro)drugs with concurrent direct activity against the hepatitis C virus and inflammation.

Wohl BM, Smith AA, Jensen BE, Zelikin AN. Wohl BM, et al. J Control Release. 2014 Dec 28;196:197-207. doi: 10.1016/j.jconrel.2014.09.032. Epub 2014 Oct 16. J Control Release. 2014. PMID: 25451544

9

Macromolecular prodrugs of ribavirin: towards a treatment for co-infection with HIV and HCV.

Smith AAA, Zuwala K, Kryger MBL, Wohl BM, Guerrero-Sanchez C, Tolstrup M, Postma A, Zelikin AN. Smith AAA, et al. Among authors: wohl bm. Chem Sci. 2015 Jan 1;6(1):264-269. doi: 10.1039/c4sc02754j. Epub 2014 Sep 16. Chem Sci. 2015. PMID: 28580095 Free PMC article.

10

Tools of gene transfer applied to the intracellular delivery of non-nucleic acid polyanionic drugs.

Kryger MB, Pedersen SL, Wohl BM, Zelikin AN. Kryger MB, et al. Among authors: wohl bm. Chem Commun (Camb). 2016 Jan 18;52(5):889-91. doi: 10.1039/c5cc08011h. Chem Commun (Camb). 2016. PMID: 26576493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters